News
January 26, 2012 — The RhinoChill IntraNasal cooling system has been nominated for one of the European medical device industry’s most prestigious awards.
January 26, 2012
News
January 26, 2012 — Amorcyte LLC, a NeoStem company, announced the enrollment of the first patient in the Amorcyte PreSERVE Phase II trial for acute myocardial infarction. The study is a multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of infarct-related artery infusion of AMR-001, an autologous bone marrow derived cell therapy enriched for CD34+ cells.
January 26, 2012
Technology
January 25, 2012 — CJPS Medical Systems announced that VitalPoint, its remote patient monitor, can be used with Microsoft Windows-based tablet PCs. This announcement comes on the heels of CJPS being the first company to waive all connectivity fees to caregivers accessing their patients' data remotely using home monitors.
January 25, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology category.
January 25, 2012News
January 25, 2012 — CardioFocus, Inc. developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF) announced that a new study in the Journal of Cardiovascular Electrophysiology demonstrated the high acute and chronic success rates achievable with a single AF ablation procedure using HeartLight EAS.
January 25, 2012
News
January 25, 2012 — Terumo Cardiovascular Systems announced today that it has entered into an exclusive agreement with LAAx Inc. to distribute the TigerPaw System II, a left atrial appendage (LAA) closure device in the United States.
January 25, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
January 25, 2012 — Physicians at University Hospitals (UH) Case Medical Center enrolled their first patient in LEVANT 2, a global, multicenter, randomized clinical trial evaluating the safety and efficacy of the Moxy drug-coated balloon for the treatment of peripheral arterial disease (PAD).
January 25, 2012Technology
January 25, 2012 — Rhode Island Hospital is the first hospital in the world to acquire the BodyTom portable, intra-operative, multi-slice computed tomography (CT) body scanner.
January 25, 2012
Technology
January 25, 2012 — Philips Healthcare announced the release of the Xper Flex Cardio Physiomonitoring system, a hemodynamic cardiac monitoring solution used to facilitate invasive investigation of heart and vascular disease.
January 25, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
January 23, 2012 – Boston Scientific Corp. said the U.S. District Court for the District of New Jersey has found all the asserted patents for a coronary stent in a lawsuit brought by Johnson & Johnson to be invalid and entered judgment in favor of Boston Scientific.
January 24, 2012
Feature | Dave Fornell
The next big advancement in cardiac imaging is likely to be computed tomography (CT) perfusion imaging. This enables one commonly available modality to image both the detailed anatomy and function of the heart at the same time. The impact on medicine could reduce healthcare costs by eliminating some hospital stays, cutting the number of tests and speeding patient diagnosis.
January 23, 2012
Technology
January 23, 2012 — CardioComm Solutions, Inc. a provider of ECG acquisition and management software solutions, received clearance from the U.S. Food and Drug Administration (FDA) for over-the-counter (OTC) sales and marketing of their consumer-based, hand-held heart rhythm monitor known as the HeartCheck Pen Handheld ECG.
January 23, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News
January 23, 2012 — A collection of real-life data from 5,000 atrial fibrillation (AF) patients across seven countries will generate invaluable insights into one of Europe's leading causes of stroke. Daiichi Sankyo Europe GmbH today announced the enrolment of the first patient into the Prevention of thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
January 23, 2012News
January 23, 2012 — Pregnant women who develop dangerous blood clots in the leg often forgo the most effective treatment for fear of harming the baby. Yet treatment to remove the clot is not only safe, it can prevent serious problems, including death, suggests research being presented at the 24th International Symposium on Endovascular Therapy (ISET).
January 23, 2012
News
January 20, 2012 - BridgePoint Medical Inc. this week signed an agreement with Covidien to exclusively license the rights to its peripheral vascular products used to treat chronic total occlusions (CTO). The agreement includes the BigBoss and Mantaray catheters and the Mantaray guidewire. The terms of the agreement were not disclosed.
January 20, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now